Select stocks that have been involved in pursuit of a vaccine have seen their shares PRICES flourish. Others like a GILD have found the endeavor a bit sobering. It had some brief spurts of brilliance fade away very quickly, some in less than a trading session, and now the chart is taking on the look of a bearish rounded top. Two others that have been battling it out for supremacy are MRNA and NVAX. The chart below of MRNA is a bit appealing, now that it has shaved off more than one quarter of its value, although it is now resting near the comforts of its 50 day SMA which it has become familiar with in 2020. NVAX has behaved a bit superior, as it deals with the overhang of the very round par number for the first time. It has undergone an extraordinary run to say the least as it had a 3 handle this January. Getting back to MRNA it has been trading sideways between 55-67 and a break out of that range either way should give valuable clues as to where this play is headed into year end.